Install
Respiratory & Pulmonology
Asthma, COPD, sleep apnea, infections, and environmental lung risks.
- 4 Tracked terms
- Last 30 days Feed window
What this topic collects on
An article joins this feed when it matches these terms. Each one is also a search of its own.
Related topics
- Cardiology & Metabolic Health
- Oncology & Hematology
- Neurology & Neuroscience
- Orthopedics & Sports Medicine
- Gastroenterology & Hepatology
- Endocrinology & Hormones
- Nephrology & Urology
- Dermatology
- Rheumatology & Autoimmune
- OB‑GYN (Women’s Health)
- Pediatrics & Adolescent Health
- Geriatrics & Healthy Aging
- Ophthalmology & Vision
- ENT (Ear, Nose & Throat)
- Dentistry & Oral Health
Latest in Respiratory & Pulmonology
Understanding AAIRS Clinic & Troy Sleep Center Reviews and Sleep Testing Options
11+ hour, 18+ min ago (554+ words) AAIRS Clinic & Troy Sleep Center is a multi-specialty medical practice in Troy, Michigan, that provides adult and pediatric sleep testing. Available formats include overnight studies in a sleep laboratory and home sleep apnea testing for eligible adults. The practice is…...
Firms tackle sleep apnea with innovation - Chinadaily.com.cn
15+ min ago (635+ words) Chinese medical device makers are increasingly deploying artificial intelligence in home sleep apnea machines, aiming to make treatment easier to use and sustain as they compete for a larger share of China's growing market. BMC Medical, a Chinese respiratory health…...
MyPollenIQ Launches Free Live Pollen Tracker for Allergy Sufferers Across the USA and Canada
1+ hour, 54+ min ago (62+ words) openPR.com MyPollenIQ Launches Free Live Pollen Tracker for Allergy Sufferers Across the USA and Canada Press release from: ABNewswire Permanent link to this press release: You can edit or delete your press release MyPollenIQ Launches Free Live Pollen Tracker…...
UTHR: Expanding into pulmonary fibrosis and COPD, targeting multi-billion revenue growth with new therapies
3+ hour, 21+ min ago (78+ words) tradingview.com A major strategic shift is underway, expanding from orphan pulmonary hypertension to large pulmonary fibrosis and COPD markets, with multiple new products and formulations in late-stage development. Revenue is projected to grow significantly, supported by robust clinical data,…...
Cumulus Neuroscience, Muse by Interaxon Partner on Sleep EEG for Clinical Trials
10+ hour, 1+ min ago (515+ words) Managing Editor Michael P. Barbella has worked as a journalist for nearly 25 years, reporting for newspapers, television and trade magazines. He began his career chronicling North Jersey politics, education, business and lifestyle for two daily newspapers before lending his skills to…...
Two Thirds of Preschoolers Switched to Alyftrek Reached Normal Sweat Chloride in Small Cystic Fibrosis Trial
3+ hour, 22+ min ago (657+ words) Children aged 2 to 5 with cystic fibrosis who switched from Trikafta to the newer once-daily drug Alyftrek saw their sweat chloride levels fall further, with about two-thirds reaching the range considered normal. Vertex Pharmaceuticals presented the data as a late-breaking abstract…...
SleepRes Receives Frost & Sullivan's 2026 North America New Product Innovation Recognition for Excellence in Positive Airway Pressure Device Innovation????
11+ hour, 39+ min ago (92+ words) Frost & Sullivan commends SleepRes for setting a high standard in product innovation, clinical integration, and patient-centric design within the Positive Airway Pressure Devices industry. The company’s vision, supported by FDA 510(k) clearance and a strong clinical foundation, is shaping the…...
Experimental treatment eases blood flow in PH-ILD patients' lungs
6+ hour, 38+ min ago (688+ words) Inhaled therapy Mosliciguat now being tested in a Phase 3 clinical trial Written by Margarida Maia, PhD | Sept. 14, 2026 Mosliciguat, an inhaled treatment being developed by Pulmovant, was well tolerated and more effective than a placebo at improving blood flow through the…...
EU-backed investment fuels nasal spray trials for viral lung treatments
7+ hour, 39+ min ago (13+ words) The Brussels Times...